We are live on ! Find out more
MYOV

Myovant Sciences Ltd.
MYOV

Delisted

MYOV was delisted on the 9th of March, 2023.

Back to rankings

31 hedge funds and large institutions have $342M invested in Myovant Sciences Ltd. in 2018 Q2 according to their latest regulatory filings, with 7 funds opening new positions, 7 increasing their positions, 5 reducing their positions, and 8 closing their positions.

New
Increased
Maintained
Reduced
Closed

40% more repeat investments, than reductions

Existing positions increased: 7 | Existing positions reduced: 5

28% more capital invested

Capital invested by funds: $267M → $342M (+$74.3M)

3% less funds holding

Funds holding: 32 → 31 (-1)

13% less first-time investments, than exits

New positions opened: 7 | Existing positions closed: 8

33% less funds holding in top 10

Funds holding in top 10: 3 → 2 (-1)

Holders
31
Holders Change
-1
Holders Change %
-3.13%
% of All Funds
0.71%
Holding in Top 10
2
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-33.33%
% of All Funds
0.05%
New
7
Increased
7
Reduced
5
Closed
8
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

1
Janus Henderson Group
Janus Henderson Group
United Kingdom
+$24.5M
2
EAM
Eventide Asset Management
Massachusetts
+$22.5M
3
Lord, Abbett & Co
Lord, Abbett & Co
New Jersey
+$22.2M
4
T. Rowe Price Associates
T. Rowe Price Associates
Maryland
+$4.28M
5
Millennium Management
Millennium Management
New York
+$1.85M

Top Sellers

1
BlackRock
BlackRock
New York
-$9.7M
2
D.E. Shaw & Co
D.E. Shaw & Co
New York
-$7.45M
3
Adage Capital Partners
Adage Capital Partners
Massachusetts
-$3.71M
4
TCM
Tekla Capital Management
Massachusetts
-$3.2M
5
EU
Emory University
Georgia
-$1.16M
Name Holding Trade Value Shares
Change 		Change in
Stake
BB
1
BB Biotech
Switzerland
$80.2M – – –
RCM
2
RA Capital Management
Massachusetts
$64.7M – – –
EAM
3
Eventide Asset Management
Massachusetts
$36.6M +$22.5M +1,028,108 +179%
NCM
4
NovaQuest Capital Management
North Carolina
$27.2M – – –
Lord, Abbett & Co
5
Lord, Abbett & Co
New Jersey
$26.6M +$22.2M +1,015,304 +692%
Janus Henderson Group
6
Janus Henderson Group
United Kingdom
$25.7M +$24.5M +1,123,397 New
Adage Capital Partners
7
Adage Capital Partners
Massachusetts
$16M -$3.71M -170,000 -20%
T. Rowe Price Associates
8
T. Rowe Price Associates
Maryland
$15.4M +$4.28M +196,094 +41%
Norges Bank
9
Norges Bank
Norway
$13.7M – – –
BlackRock
10
BlackRock
New York
$12.5M -$9.7M -444,378 -45%
RSCM
11
Rock Springs Capital Management
Maryland
$6.75M – – –
Millennium Management
12
Millennium Management
New York
$4.38M +$1.85M +84,568 +79%
JP Morgan Chase
13
JP Morgan Chase
New York
$2.83M +$365K +16,719 +16%
EU
14
Emory University
Georgia
$2.81M -$1.16M -53,332 -30%
BAMCO Inc
15
BAMCO Inc
New York
$1.33M +$1.27M +58,200 New
PIM
16
Platinum Investment Management
Australia
$1.24M – – –
State Street
17
State Street
Massachusetts
$1.07M -$4.37K -200 -0.4%
Swiss National Bank
18
Swiss National Bank
Switzerland
$647K – – –
Morgan Stanley
19
Morgan Stanley
New York
$431K +$378K +17,316 +1,130%
MC
20
Matisse Capital
Oregon
$349K +$333K +15,250 New
Lazard Asset Management
21
Lazard Asset Management
New York
$331K +$316K +14,489 New
Renaissance Technologies
22
Renaissance Technologies
New York
$297K +$284K +13,000 New
Bank of New York Mellon
23
Bank of New York Mellon
New York
$271K – – –
WAM
24
Weiss Asset Management
Massachusetts
$218K – – –
PNC Financial Services Group
25
PNC Financial Services Group
Pennsylvania
$40K – – –
1
2

MYOV Hedge Fund Activity: Q2 2018 in Review

31 of the 4,368 institutional investors tracked by Wall St. Rank reported a position in Myovant Sciences Ltd. (MYOV) for Q2 2018, worth a combined $342M — up 28% from $267M a quarter earlier.

Sellers outnumbered buyers: 8 funds closed out of MYOV and 7 opened new positions — a net loss of 1 holder — while 5 trimmed existing stakes and 7 added.

The largest buyer was Janus Henderson Group, opening a new position worth an estimated $24.5M. The largest seller was BlackRock, cutting an estimated $9.7M.

  • 31 institutional investors held Myovant Sciences Ltd. (MYOV) as of Q2 2018, down from 32 in Q1 2018.
  • Funds reported $342M of Myovant Sciences Ltd. stock for Q2 2018, up 28% quarter-over-quarter.
  • 7 funds opened new Myovant Sciences Ltd. positions in Q2 2018 and 8 closed out, a net change of -1 holder.
  • The largest Myovant Sciences Ltd. buyer in Q2 2018 was Janus Henderson Group, an estimated $24.5M added.
  • The largest Myovant Sciences Ltd. seller in Q2 2018 was BlackRock, an estimated $9.7M sold.

Based on aggregated 13F filings for Q2 2018.